Showing results (2371-2380 of 2,462) with videos related to

Sort By:
Pageof 247
Elife|September 4, 2019
Interferon lambda 4 impacts the genetic diversity of hepatitis C virusM Azim Ansari, Elihu Aranday-Cortes, Camilla Lc Ip, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 12, 2024
Neoadjuvant Cisplatin, Gemcitabine, and Docetaxel in Sarcomatoid Bladder Cancer: Clinical Activity and Whole Transcriptome AnalysisBurles A Johnson Iii, Benjamin A Teply, Catherine Kagemann, et al.
Nature Microbiology|January 3, 2025
Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemicWilhelm Furnon, Vanessa M Cowton, Giuditta De Lorenzo, et al.
Nature Medicine|April 26, 2011
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapyJoachim Lupberger, Mirjam B Zeisel, Fei Xiao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2019
Phase II Evaluation of Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus-Associated Oropharynx Squamous Cell CarcinomaDaniel J Ma, Katharine A Price, Eric J Moore, et al.
International Journal of Radiation Oncology, Biology, Physics|October 29, 2022
A Prospective Study of Mucosal Sparing Radiation Therapy in Resected Oropharyngeal Cancer PatientsJustin D Anderson, Todd A DeWees, Daniel J Ma, et al.
International Journal of Particle Therapy|October 23, 2020
The Importance of Verification CT-QA Scans in Patients Treated with IMPT for Head and Neck CancersJaden D Evans, Riley H Harper, Molly Petersen, et al.
Annals of Surgery|August 1, 2018
Does Surgical Margin Impact Recurrence in Noninvasive Intraductal Papillary Mucinous Neoplasms?: A Multi-institutional StudyVikrom K Dhar, Nipun B Merchant, Sameer H Patel, et al.
Pageof 247